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Abstract

Chronic or persistent pain is a growing global health problem. Effective management of pain emerging in
childhood may prevent long-term health and vocational consequences. Internationally, paediatric pain
services are a limited resource and, as such, must strive to improve equity, outcomes, and value for money. The
Paediatric electronic Persistent Pain Outcomes Collaboration (PaedePPOC) is a binational paediatric
outcome measurement centre that aims to measure, benchmark, and improve children's specialist pain
services in Australasia. This study documents the establishment of PaedePPOC and presents baseline and
initial outcome data. Binational consensus meetings determined the measures. Governance structures,
collection protocols, information technology, site-specific logistics, and onsite training were achieved within
18 months. Children and parents complete baseline and progress questionnaires. Seven of 10 Australasian
services provided data to PaedePPOC, with 1432 patients enrolled until June 2018. At baseline, patients were
12.4 ± (3.0) years, 68% female, 93% Australian-born, and 5% Aboriginal and/or Torres Strait Islander people.
Most had moderate-severe functional disability and impaired quality of life, with pain affecting school
attendance and employment. Opioid-containing medicines were used often or daily by 16%. Patients
completing outcome measures at treatment end reported clinically significant improvement in pain intensity
(49% of patients), functional ability (59%), and quality of life (69%). The PaedePPOC initiative has been
successfully integrated into children's pain services, yielding timely point-of-care information to support
clinicians and families, and valuable binational and service data to inform quality improvement and future
sector planning.
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SUMMARY [22 words]
PaedePPOC has been successfully established and embedded in Australian children’s persistent pain
services, laying the foundation for sector-wide benchmarking and quality improvement.

KEY WORDS
Paediatric / pediatric, child, persistent pain, outcomes, benchmark, registry
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BAP-PIQ
BPI-Mod
ePPOC
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PaedePPOC
Parent
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PRG
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Australian Health Services Research Institute
Bath Adolescent Pain Questionnaire
Bath Adolescent Pain Parent Impact Questionnaire
Modified Brief Pain Inventory
electronic Persistent Pain Outcomes Collaboration
Functional Disability Inventory
National Pain Strategy
Paediatric electronic Persistent Pain Outcomes Collaboration
Adult legal guardian and carer for a child, whether the
biological parent or in loco parentis
Pediatric Quality of Life
Paediatric Reference Group
Patient-Reported Outcome Measures
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ABSTRACT [236/250 words]
Chronic or persistent pain is a growing global health problem. Effective management of pain
emerging in childhood may prevent long-term health and vocational consequences. Internationally,
paediatric pain services are a limited resource and, as such, must strive to improve equity, outcomes
and value for money. The Paediatric electronic Persistent Pain Outcomes Collaboration (PaedePPOC)
is a bi-national paediatric outcome measurement centre that aims to measure, benchmark, and
improve children’s specialist pain services in Australasia. This study documents the establishment of
PaedePPOC and presents baseline and initial outcome data. Bi-national consensus meetings
determined the measures. Governance structures, collection protocols, information technology, sitespecific logistics and onsite training were achieved within 18 months. Children and parents complete
baseline and progress questionnaires. Seven of ten Australasian services provided data to
PaedePPOC, with 1432 patients enrolled to June 2018. At baseline, patients were 12.4±[3.0] years,
68% female, 93% Australian-born, and 5% Aboriginal and/or Torres Strait Islander people. Most had
moderate-severe functional disability and impaired quality of life, with pain affecting school
attendance and employment. Opioid-containing medicines were used often or daily by 16%. Patients
completing outcome measures at treatment end reported clinically significant improvement in pain
intensity (49% of patients), functional ability (59%) and quality of life (69%). The PaedePPOC
initiative has been successfully integrated into children’s pain services, yielding timely point-of-care
information to support clinicians and families, and valuable bi-national and service data to inform
quality improvement and future sector planning.
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INTRODUCTION [455/500 words]
Chronic or persistent pain is recognised as a significant public health problem globally,10,21,30,45,55 and
affects almost one in five Australians 9,39 and New Zealanders.20 It is associated with high costs, not
just in terms of healthcare expenditure, disability payments, and prescription-analgesic morbidity
and mortality, but also due to lost employment, productivity and social capital.1,11,34,45
Persistent pain in childhood and adolescence is similarly common50,60,64 and costly.12,37,42,63 If
inadequately treated, childhood pain can interrupt physical, cognitive, emotional and social
development.19,23,46,61 The resultant disability and comorbidities may continue into adulthood,2,40,74
with long-term consequences and costs for the individual and society.
In Australia and New Zealand, some 5-19% of adolescents and young people experience intrusive
persistent pain.9,20,39,60 However, children and adolescents who require care for persistent pain
remain relatively underserviced, with estimates that new assessments by specialist pain services are
made for less than 1% of young Australians.43 In 2018, children’s services remain few and far
between, with only nine services across Australia and one in New Zealand.
With such a small sector to support the needs of so many children with persistent pain, it is
imperative that children’s specialist pain services develop means to measure patient outcomes to
improve the quality, effectiveness, and value of care. Rigorous clinical trials and systematic reviews
identify treatments that ought to be best practice, but few include children with persistent pain.1518,24,25,27,31

Furthermore, clinical trial patients and conditions often vary markedly from real-world

clinical contexts. Measures of efficacy need to be followed by measures of effectiveness to improve
generalisability.
For many conditions and healthcare interventions, outcome registries are showing great potential to
improve the quality and value of care.44,51,76 By identifying variations in outcomes, registries allow
development of benchmarks and assessment of comparative performance at the clinic, regional,
national, and international levels.51 Examining and learning from the practices of high-performing
5

services, through a continuous quality improvement process, may lead to earlier identification and
dissemination of best practices.
Recognising this, in 2012, the Australian and New Zealand children’s persistent pain management
sector began a collaborative process to identify a minimum set of outcome domains and measures
with which to measure and compare service effectiveness and value. Parallel endeavours in the
adult persistent pain sectors in Australia,63 Canada,13 the UK,57 and USA52 have been described. To
date, USA is the only other country to report the establishment of an outcomes registry for
children’s specialist pain services (Peds-CHOIR).7 A registry has been initiated in Ontario, Canada12
but is yet to be reported.
This paper describes the political and logistic processes whereby the Australian and New Zealand
electronic Persistent Pain Outcomes Collaboration for children’s specialist pain services (PaedePPOC)
was established, and outlines the methods and resources this required. Baseline and initial outcome
data for children are reported.
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METHOD
1. History of PaedePPOC
In 2005, the Faculty of Pain Medicine of the Australian & New Zealand College of Anaesthetists (FPM
ANZCA) recognised that a national outcomes dataset would facilitate benchmarking and quality
improvement across the specialty. The Faculty established a working group to garner clinician
support for an outcomes collaboration and to identify preliminary consensus on key outcome
domains. In 2010, this group, along with other professional bodies and consumer stakeholders,
participated in a National Pain Summit that yielded the National Pain Strategy (NPS).58 One of the
NPS priority objectives was quality improvement through outcomes measurement, reporting, and
national benchmarking. The NPS also recognised the importance of developing programs to
specifically evaluate persistent pain management in children and adolescents.58
The ability to realise this important objective came in 2012 with the announcement that the New
South Wales (NSW) Ministry of Health would fund the establishment of an outcomes database for
specialist pain management services. This followed considerable planning and advocacy by the NSW
Agency for Clinical Innovation (ACI) Pain Management Network and a Ministerial Taskforce.59 The
resultant initiative, named the electronic Persistent Pain Outcomes Collaboration (ePPOC) would
ensure consistent and standardised data collection and reporting in NSW services, and across
Australia and New Zealand.65
Throughout this evolution, members of the paediatric service sector were involved in the various
professional bodies and meetings, advocating for children and their families. Advocacy efforts were
facilitated by the formation of a Pain in Childhood Special Interest Group within the Australian and
New Zealand Pain Societies in 2011.4 Consequently, ePPOC became an initiative of the pain
management sector to improve outcomes for all patients experiencing persistent pain, irrespective
of their age.
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Implementation of ePPOC began in 2013 when the Australian Health Services Research Institute
(AHSRI), based at the University of Wollongong, was chosen to develop and manage the ePPOC and
PaedePPOC projects. AHSRI had established similar outcome collaborations in the related fields of
rehabilitation (AROC, the Australasian Rehabilitation Outcomes Centre) and palliative care (PCOC,
the Palliative Care Outcomes Collaboration) and had experience in implementing national patient
outcome measurement suites and reports for benchmarking, research, and governance. This was,
however, the first time specialist children’s services had been involved alongside adults’ services
from the inception of such a collaboration. Whilst there is much in common, important differences
between adult and children’s service models, client needs, and validated outcome measures
necessitated a parallel but separate development and reporting process.
2. Governance
During establishment, a National Reference Group was formed comprising governmental and clinical
representatives from the Australian states and territories and New Zealand. This group refined the
ePPOC minimum dataset for adults’ services, and developed the protocol for data collection and
implementation resources. A Paediatric Reference Group (PRG) supervised the parallel development
of the paediatric dataset and collection protocol for children’s services (PaedePPOC). Following the
implementation phase of ePPOC and PaedePPOC, a Management Advisory Group and a Scientific
and Clinical Advisory Committee were formed to oversee and support the continued development of
the outcome registries.28 These advisory groups have recently been amalgamated to form a singular
Clinical and Management Advisory Committee (CMAC). Paediatric representation continues within
this framework.
Implementation and the day-to-day operations of PaedePPOC are managed by AHSRI. The staff
currently employed to support ePPOC and PaedePPOC are a director, administrator and statistician,
and two project coordinators whose roles are to assist services to collect, interpret and use their
data for quality improvement purposes.
8

3. Ethics and Privacy
The establishment of ePPOC and PaedePPOC were approved by the University of Wollongong
Human Research Ethics Committee. This approval allows non-identified patient data to be collected
from participating pain services for the purposes of reporting, quality assurance, benchmarking and
research. ePPOC and PaedePPOC were deliberately established as patient non-identified to allow
collection of information from the pain services without the requirement for explicit patient consent
for this information to be forwarded. This was done to ensure that the database is complete and
representative, and that the resulting reports, quality improvement initiatives, benchmarks and
research are meaningful and accurate.
Individual services own their data and are responsible for the privacy and ethical use of identified
and re-identifiable healthcare information stored within their own systems. Every six months, each
participating service sends a patient non-identified data extract to PaedePPOC via a secure upload
facility. Although non-identifiable once uploaded, the PaedePPOC data contains a statistical linkage
key,56 computed automatically from mandatory fields by the software at the time of data entry. This
enables data from multiple episodes of care at one centre, or multiple centres across childhood and
adulthood, to be linked longitudinally without identifying the source.
Services receive confidential reports of their own facility-level data alongside the pooled data for all
services, whereas public reports contain only pooled data. This service-level anonymity is critical to
the success of the collaboration as it helps to remove concerns that there may be external incentives
or ramifications for achieving, or not achieving, particular outcomes.
The PaedePPOC data stored at the University of Wollongong is available to be used for approved
research projects by participating pain management services and external researchers. A Data
Access Working Group is responsible for reviewing and approving applications for data and providing
advice to applicants. All research projects using ePPOC and PaedePPOC data must obtain separate
ethics approval.
9

4. PaedePPOC Minimum Dataset
During 2013, the PRG followed closely the progress and decisions in the development of the adult
minimum dataset. It was considered important to maintain the same core outcome domains across
the lifespan, whilst recognising the need to employ developmentally appropriate and age-validated
measurement tools within each domain. In order to arrive at agreement on the domains and
measures, members of the PRG performed a pragmatic literature review, conducted an email
discussion group, and attended two face-to-face consensus meetings.
A number of guiding principles were followed in determining the minimum dataset. Of critical
importance were the priorities of ensuring maximal clinical utility whilst minimising the child/family
data collection burden. Accordingly, preference was given to measures that were easy, brief, free to
use, validated for relevant ages and contexts, sensitive to change, and facilitated clinical processes
such as triage, assessment and monitoring of progress. In addition, it was agreed that PROMs should
be preeminent. Parent-proxy measures would also be collected where possible to allow assessment
of children too young or unable to complete the patient-rated tools, and to allow investigation of
child-parent dyads.
All measures had to serve at least one of the following functions:
•

P – Patient or problem descriptors i.e. pain, comorbidity, disability;

•

E – Exposure descriptors i.e. specialist pain service type and timing;

•

O – Outcomes (child and/or parent reported).

4.1 Domains
The PRG considered the domains recommended for the adult minimum dataset together with the
PedIMMPACT Consensus outcome domains developed for reporting paediatric persistent pain
clinical trials.53 The final list of outcome domains for children’s services (Table 1) is a composite of
the two sources with some omissions and one addition. Omitted were the PedIMMPACT domains
‘Treatment-emergent adverse symptoms/events’ and ‘Global judgement of satisfaction with
10

treatment’ due to lack of validated patient-reported measures and potential bias in the absence of
an independent assessor. ‘Economic factors’ was omitted due to the burden of collecting reliable
data. It was agreed that consideration of these domains be revisited for subsequent versions. The
PRG included the impact of the child’s pain on their parents, as this was considered an important
baseline, progress and outcome domain with immediate clinical relevance.
Table 1 here

4.2 Data items
4.2.1 Patient and Problem Measures
Baseline demographics include age, sex, height and weight, school stage, employment, residential
postcode, compensation status, Indigenous status and country of birth. The child’s comorbidities
(chronic disease, mental health, cancer) and disabilities (sight or hearing impairment, intellectual or
physical disability) are also recorded by the parent. Pain problem descriptors include parentreported cause at onset and how long the pain has been experienced. Both parent and child report
the frequency and location of the pain. The latter is recorded as the single worst location, and all
other locations of pain on a body-map.72
4.2.2 Exposure Measures
Recognising that there is considerable variation in treatment between services, the collaboration
seeks to capture service activity data in order to determine which types and intensities of treatment
were associated with better outcomes. There is also interest in evaluating best value for outcome.
Wait-time is calculated as the number of days from receipt of referral by the service to commencing
an episode of care. An episode of care is defined as a continuous period of care for a patient within
one pain management service. Episode start and end dates, referral source and disposition at
discharge are recorded. Within an episode, patients may receive different types of care usually
predicated by their progress. These different types of care are categorised into pathways (e.g.
11

individual appointments, group program, procedural intervention) to enable comparative evaluation
of the outcomes of different pathways in addition to overall episode outcome. Within an episode of
care, each service event date, duration, and type is recorded. Remotely-delivered events by
telephone and telehealth are also captured.
4.2.3 Outcome Measures (PROMs)
The outcome measures chosen to assess each domain were determined by evidence-informed and
pragmatic consensus. Along with the guiding principles outlined previously, the specific materials
considered included: measures in current use by member services; individual measures
recommended by the PedIMMPACT Consensus,53 and a later FDA Scientific Workshop on paediatric
analgesic trial design and measures;6 an unpublished literature review conducted by a member
service (Pain Research Unit, Sydney Children’s Hospital Randwick Discussion Document
(unpublished) 2011); together with recently developed and emerging measures. Furthermore, the
PRG explored the progress of similar initiatives in other nations with a view to the possibility of
aligning in the interests of future international benchmarking and research.
Three child-report questionnaire batteries were developed to accommodate different
developmental levels—5-7 years, 8-12 years and 13-18 years—requiring different age-valid
measures. A separate battery for patients aged under 5 years was considered, however due to the
small number typically presenting to services, it was decided that specific measures for this age
group would not be included. Children aged 5-7 years, with assistance from a clinician or parent,
complete 28 questionnaire items; 8-12 year olds complete 44 items; and 13-18 year old adolescents
complete 51 items. Parents of children 0-18 years answer 61 items relating to their child and 62
items relating to themselves at referral. Subsequent questionnaires are of equal length except that
parents only need to complete 52 items relating to their child. Individual services can weigh up the
benefit and burden of collecting additional measures for local use or research. Most participants
choose to complete questionnaires online, and parents typically report that the child and parent
12

questionnaires each take approximately ten minutes to complete. However, if the questionnaires
are delivered verbally (due to poor literacy for example), completion may take around 20 minutes.
These timeframes are comparable to those reported for the Peds-CHOIR assessment measures.7
Table 2 lists the outcome domains and assessment tools that constitute the core minimum dataset.
Each of the standardised assessment tools are described in more detail below.
Table 2 here
Body Map
The body map developed by the Childhood Arthritis and Rheumatology Research Alliance (CARRA)72
is used to record the location of the main and additional pain. The delineated body regions in this
map make online selection of areas easier, and also facilitates standardised reporting of pain
location.
Modified Brief Pain Inventory
The Brief Pain Inventory (BPI)14 is a measure assessing pain intensity and pain interference with daily
activities. PaedePPOC assesses pain intensity in children aged eight and over using questions based
on the four pain intensity questions in the BPI, but with slight modification to ensure they are
appropriate for children experiencing chronic pain. Four questions ask the child to rate their pain
intensity at its usual (instead of “average”14), worst, and least in the last week, and their pain
intensity now. Pain intensity is rated on a 0 to 10 numeric rating scale where 0 represents “no pain”,
and 10 represents “pain as bad as you can imagine” in the adolescent questionnaires and “worst
pain ever” for children aged 8-12 years. Parents complete this assessment tool regardless of the age
of their child. Children and parents are asked to rate the pain intensity over the past week,
consistent with recommendations for a longer assessment period in chronic pain.53 Similar questions
are included in Peds-CHOIR, with pain reported over the past month.4 Pain intensity is reported by
PaedePPOC as mild (0-4), moderate (5-6) or severe (7-10). An improvement of 30% or more from
baseline has been recommended as representing moderate clinically significant improvement for
13

adult studies of chronic pain.22 This measure of improvement is used in ePPOC for the adult
population and was also adopted in PaedePPOC for consistency.
While the BPI is not commonly used in paediatric studies, PaedePPOC chose to include pain intensity
questions based on those in the BPI due to ease of use and scoring, and to be consistent with the
questions asked in ePPOC. In addition, studies have shown numeric pain rating scales similar to
those used in PaedePPOC to be valid and psychometrically sound in paediatric patients.8,54,73
Faces of Pain Scale-Revised
Children aged five to seven complete the Faces of Pain Scale – Revised (FPS-R)41 to report the
severity of their pain. This assessment tool presents six faces showing increasing levels of pain. The
clinician or parent reads standardised instructions, which include asking the child to indicate which
face reflects the pain the child feels. The six faces are scored 0, 2, 4, 6, 8 and 10, with 0 representing
“no pain” and 10 “very much pain”. The FPS-R is freely available through the International
Association for the Study of Pain. It is widely used and available in many languages. Consistent with
the pain severity questions described for the older children, a 30% or greater improvement is
considered clinically significant for the purposes of reporting in PaedePPOC.
Functional Disability Inventory
The Functional Disability Inventory (FDI)75 is a tool used to assess functional limitation in children.
Fifteen items ask patients whether they have had any physical trouble or difficulty doing specified
activities over the past two weeks. Items are rated on a five point scale where 0=No trouble, 1=A
little trouble, 2=Some trouble, 3=A lot of trouble and 4=Impossible. A total score is calculated by
summing responses on each item, giving a range of 0-60 with higher scores reflecting higher levels of
disability. The FDI is a widely used assessment tool and has been recommended as a functional
outcome measure in studies of paediatric chronic pain.53 Severity bands for the FDI are no/minimal
disability (0-12), moderate disability (13-29) and severe disability (>29).49 At inception we were
unable to find published recommendations regarding clinically meaningful change on this measure,
14

so the PRG suggested that for the purposes of PaedePPOC, this should be defined as a change of five
or more points coupled with a change to a different severity category. Subsequently, another group
published a more rigorous recommendation for reliable clinical change being ≥ 7.8 point reduction
coupled with a change in FDI severity category.62 Nevertheless, to enable longitudinal service
evaluation, PaedePPOC currently continues to use its original definition of clinically meaningful
change.
Pediatric Quality of Life Inventory
PaedePPOC uses the Pediatric Quality of Life (PedsQL)67 Generic Core Scales to measure healthrelated quality of life. Parents and children complete the age-appropriate version. The PedsQL
assesses physical, emotional, social and school functioning, and asks how much of a problem the
child has had with each of these over the past week. The tool consists of 23 questions each rated on
a five point scale where 0=Never [a problem], 1=Almost never, 2=Sometimes, 3=Often and 4=Almost
always. For children aged 5-7 years the scale is clinician-administered and rated on a three point
scale where 0=Never [a problem], 2=Sometimes and 4=Almost always.
All PedsQL item responses are reverse scored and transformed to a 0-100 scale, with higher scores
indicating better health-related quality of life. Results are reported for the total score, each of the
subscales (physical, emotional, social and school functioning) and two summary scores reflecting
psychosocial and physical health. PaedePPOC also reports the single item assessing sleep.
The PedsQL is widely used and recommended as a tool to measure parent and child report of
physical, emotional, school and social functioning in studies of paediatric chronic pain.53 Minimal
clinically meaningful difference is measured as a 4.4 point change in the child self-report total score,
and a 4.5 point change in the adult proxy-report total score.67
Bath Adolescent Pain Questionnaire (BAPQ) – Pain Specific Anxiety subscale
The BAPQ is a 61 item measure which assesses the impact of pain over seven domains: social
functioning, physical functioning, depression, general anxiety, pain specific anxiety, family
15

functioning and development.26 The BAPQ has been specifically developed for use with adolescents
experiencing chronic pain and has been shown to be a reliable and valid measure in this
population.26,33 While the entire assessment tool was considered for inclusion in the PaedePPOC
minimum dataset, the preference was for measures that could span multiple age groups, such as the
FDI and PedsQL. Given the importance of assessing pain-related cognitions however, the PRG
decided to include the seven-item pain-specific anxiety subscale of the BAPQ for adolescent patients
to complete.
This subscale assesses worries or concerns the patient has about their pain. Patients are asked to
read a list of statements and mark the answer that best describes how often they have experienced
each in the past two weeks. Items are rated using a five point scale, where 0=Never, 1=Hardly ever,
2=Sometimes, 3=Often and 4=Always. Item scores are totalled with a range of 0 to 28. Higher scores
indicate higher levels of pain-specific anxiety. Severity bands and guidelines for clinically significant
change on this measure have not yet been established.
Bath Adolescent Pain Parent Impact Questionnaire (BAP-PIQ)
The BAP-PIQ has been specifically developed to assess the impact of a child’s pain on the life of the
parent and has been shown to be a reliable and valid measure.47 The questionnaire consists of eight
subscales addressing depression (9 items), anxiety (6 items), child-related catastrophizing (5 items),
self-blame and helplessness (7 items), partner relationship (7 items), leisure functioning (8 items),
parental behaviour (11 items) and parental strain (9 items). Parents are asked to read each
statement and indicate how often each was experienced in the last two weeks. Items are rated using
a five point scale, where 0=Never, 1=Hardly ever, 2=Sometimes, 3=Often and 4=Always. Scores are
reported for each subscale, with higher scores reflecting greater impairment. The current paper
focusses on child baseline and outcome data however, and scores on the BAP-PIQ will not be
reported here.
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It should be noted that the PRG agreed to these domains, data items and assessment tools with the
expectation that the minimum dataset could be updated if required. A process allowing for
continuous review and evaluation was therefore implemented, whereby participating services and
stakeholders can submit requests to PaedePPOC justifying a change or addition to the data
collection. These suggestions are then discussed among the PRG and also reviewed at CMAC
meetings. For logistical reasons and to maintain longitudinal information, release of a new dataset is
only expected every few years. To date, there has been one version update, incorporating minor
changes to data items and code sets rather than assessment tools. However, planning is underway
to implement more significant changes in a future version, including introduction of a specific
measure to assess sleep, and an item enabling collection of pain diagnoses. As has occurred in
ePPOC, candidate measures and data items will first be trialled and evaluated in a select number of
pain management units before a decision is made to incorporate into the PaedePPOC software and
minimum dataset.
5. Participants
All specialist paediatric pain management services in Australia and New Zealand are eligible to
participate in PaedePPOC. To date, seven of ten Australasian paediatric services have implemented
PaedePPOC at their service. Another two services have recently joined and will begin to submit data
in 2019.
6. Data collection and quality
The purpose-built software (epiCentre), protocol for collecting data, Data Policy and Data Dictionary
are described in detail elsewhere.65 In brief however, questionnaires are generated electronically
when a referral is logged in epiCentre. Depending on child/parent preference they can be emailed
and completed online, posted, or completed in clinic either on paper or on a tablet. The subsequent
primary collection points are at the end of the episode of care, and 3-6 months after the episode has
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ended. Questionnaires can also be collected throughout the episode of care to review progress, as
deemed appropriate by individual pain services.
epiCentre facilitates data checking and error minimisation by incorporating a number of validation
checks at point-of-entry. These include mandatory fields (e.g. sex, date of birth, questionnaire
completion dates) and logic checks (e.g. an episode of care beginning before a referral has been
received). Following each data submission, PaedePPOC produces a short report summarizing the
data provided and identifying omissions or improbable data. This information is discussed with each
pain management service, with services encouraged to correct their data and resubmit.
7. Reporting
Individual patient scores and progress reports are generated electronically by pain service staff using
epiCentre. These individual reports enable documentation at the clinic level, and facilitate discussion
with the individual child, family and referrer. Once a child and family have completed more than one
set of PaedePPOC questionnaires, the report generated will graphically compare their most recent
scores with baseline scores (see example in Figure 1). This enables children as developmentallyappropriate, families, and referrers to visualise quantitatively the changes that they may have
observed qualitatively.
Figure 1 here
Each participating pain management service receives a detailed report every six months (JanuaryDecember and July to June), comparing the service’s data along-side aggregated data from all
participating services. Reports contain a descriptive profile of patients seen during the reporting
window, the service activity profile and service outcomes. The proportion of patients who achieve
pre-defined clinically significant change from baseline is also reported. An online example report is
publicly available at https://ahsri.uow.edu.au/eppoc/reports/.29 Each pain service report is relayed
in confidence to the service’s nominated contact person and is not released or discussed externally
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by PaedePPOC. Individual services may elect to discuss their own data locally, or in benchmarking or
scientific meetings.
ePPOC and PaedePPOC also release an annual report which describes, at a composite level, the
patients referred to adult and paediatric pain units in Australasia, along with the services they
received and the outcomes achieved.29 As the national and service-level reports describe patients,
services and outcomes over a discrete period, they may be used to evaluate the impact of changes in
health care delivery. For example, a pain service interested in trialling a new form of pain
management can use a current report as a baseline, with future reports reflecting outcomes as a
result of the new treatment.
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RESULTS
Implementation and challenges
PaedePPOC was established in 2013 and implemented in paediatric pain management services from
2014. As at January 2019, nine of the ten specialist paediatric pain management services in Australia
and New Zealand had joined the collaboration.
Many of the challenges faced during this implementation period mirrored those experienced during
implementation of ePPOC, the collaboration for adult pain services. As described previously,65 one of
the least expected hurdles was the difficulty installing the software program epiCentre at each pain
management service. epiCentre is a small program, however obtaining support and security
clearance from information technology (IT) departments within hospitals was time consuming and
meant delays in joining the collaboration for many services. Periodic updates to the software also
require hospital IT involvement, and while the installation of these is less onerous, establishing an
ongoing relationship with each hospital’s IT staff has become a necessary function for ePPOC and
PaedePPOC.
Another challenge identified in the implementation phase of both ePPOC and PaedePPOC was to
embed the standardised protocol and terminology into the unique and often well-established
processes and practice of each pain management service. This is an important issue because
ensuring that questionnaires are collected at consistent points in and after an episode is crucial to
obtaining meaningful and comparable data. ePPOC staff attempted to facilitate this process by firstly
visiting each new service and together developing a ‘process map’. This outlines the typical patient
pathway through the pain management service and highlights when and how to collect the
questionnaires, and when to enter data into epiCentre. This education and training has become an
important ongoing function for ePPOC staff, involving training of new pain service staff, checking
that submitted data complies with the protocol, and assisting pain services to understand and use
their reports.
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An ongoing hurdle for many services is the data entry requirements of PaedePPOC participation.
epiCentre is a stand-alone program, and there is therefore some double entry of data (e.g. name,
date of birth, referral date) into epiCentre and the hospital’s medical record system. There is no easy
solution to this due to the variety of hospital systems used in each jurisdiction, and limited IT
resources within ePPOC and the individual hospitals. In recognition of this additional burden for pain
service staff however, ePPOC has attempted to promote use of epiCentre through continuously
improving useability of the software and highlighting the clinical benefits of point-of-care data and
tracking of patients.
Despite these challenges, seven of Australasia’s ten specialist paediatric pain services had joined the
collaboration and provided data during the period January 2014 to June 2018. These services were
all located in Australia, in the states of Queensland, NSW and Victoria, and based in major cities. All
services are tertiary referral pain services in a hospital setting. Six services are publically funded and
one is a private service. Pain services joined PaedePPOC at different times throughout this period,
with the average participation period being 36 months (range 20 to 50).
The services submitted data for 1432 children. Questionnaires were completed online (80.9%), in
clinic (15.6%) and via post (3.5%). Within returned questionnaires, over 95% of all assessment tools
were validly completed, suggesting patient and parent acceptability of the measures.
Referral questionnaires were completed by 1076 children and 1108 parents. Approximately one in
four patients (n=356, 24.9%) and parents (n=324, 22.6%) had not completed a referral questionnaire
at the time of data extraction. The reasons for this include that they were referred and registered in
epiCentre but did not engage further with the pain service, they had not yet completed or been sent
a questionnaire at the time the data were submitted to PaedePPOC, or they were unable to
complete a questionnaire. Of the parents who reported that their child was unable to complete their
questionnaire (n=102), 96 reported a reason. These were refusal (4.2%), that their child was too
young (41.7%), cognitively unable (17.7%), physically unable (8.3%), non-English speaking (1.0%) or
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‘Other’ (27.1%). Free text responses to the ‘Other’ option were varied, but common answers were
that their child was planning to do it later, needed assistance, could not read, or was unwell or too
distressed.
Six hundred and forty two children completed their episode of care at the pain management service
during the period of data collection. Of these, 206 children and 199 parents completed both a
referral questionnaire and another at the end of their episode. Approximately two thirds of patients
who had completed an episode of care, and their parents, had therefore not completed episode end
questionnaires (Figure 2). Reasons include that they had not yet been sent the episode end
questionnaires, had not yet returned them, or they were unwilling or unable to do so. Participating
services have evolving procedures for determining when an episode of active care has been
completed, for capturing data at the last face-to-face appointment or despatching the
questionnaires post hoc, and for sending reminders to complete and return them. Questionnaire
return rates are included in individual pain unit reports, enabling units to track how return rates
change with process improvements, over successive years.
Figure 2 here
Description of patients at referral
The demographic characteristics and comorbidity profile of children at referral are shown in Table 3.
Patients were generally referred to the children’s pain management service by a specialist
practitioner (70.9%).
Table 3 here
At referral, 56.5% of parents reported that their child had experienced pain for more than 12
months. Most also described their child’s pain as ‘always present’ (70.3%). Parents attributed the
onset of their child’s pain to injury (21.6%), illness (15.9%), after surgery (7.4%), ‘no known cause’
(40.0%) or ‘other’ (15.1%). The main pain was most commonly experienced in the lower limbs
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(28.4%), back (17.0%), abdomen (16.4%), and head (15.4%). Approximately 1 in 4 patients (26%) had
pain in one region only, with the majority identifying multiple painful regions.
One third of the children were enrolled in primary school (Kindergarten to Year 6) and two thirds in
secondary school (Years 7 – 12). Children missed a significant number of school days in the previous
school term 1 as a result of their pain, with the number of days missed increasing with age. Young
children missed an average of 10.2 days (20.4%), children 13.0 days (26.0%) and adolescents 16.9
days (33.8%) of the school term. A small proportion (13.6%) of adolescents were in paid
employment, with pain affecting the number of hours that most (69.2%) could work.
Many children were using medications often or daily at referral: 56.0% were using paracetamol
often or daily, 44.8% anti-inflammatory medication, 32.7% anti-neuropathic medicines, 24.3%
complementary or alternative medicines, 15.7% opioid-containing medication. They also had
relatively high healthcare utilisation for age. In the preceding 3 months, on account of their pain,
children had an average of 3.6 general practitioner visits, 3.0 medical specialist visits, 3.7 allied
health appointments, 1.2 hospital emergency department presentations and 2.2 diagnostic tests.
Table 4 shows child and parent scores by child age group at referral for each of the assessment tools.
Table 4 here
Both self-report and parent-proxy pain intensity ratings indicate that on average the children’s usual
pain was in the moderate category, while pain at its worst was severe. The self-reported quality of
life of the children in this cohort appears worse than that of healthy children, those with other
chronic health conditions,66,68,69 and children with chronic pain reported in other studies using this
measure.36,71 Both child and parent report showed a trend of lower health-related quality of life with
increasing age group. Compared to their parent’s ratings, children tended to report better quality of

The school year in Australia and New Zealand is divided into four ‘terms’, each lasting approximately 10
weeks (50 school days).

1
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life overall and for most of the PedsQL subscales, consistent with cross-informant variance observed
in other studies using this measure.36,68,70,71
Scores on the FDI were most likely to fall in the moderate category, as is typically reported for
children referred for specialist pain management.49 However, the average FDI scores of 25.7 for 8-12
year olds and 26.8 for 13-18 year olds were at the high end of the moderate disability range (13 to
29), and somewhat higher than those described elsewhere.48,49,70 For example, Kashikar-Zuck et al’s
study of a large paediatric pain population reported mean scores of 19.1 and 21.7 for 8-12 and 13-19
year olds, respectively. Pain-specific anxiety, measured by the Bath Adolescent Pain Questionnaire,
was similar to that reported in other of studies of paediatric chronic pain patients.5,35
Patient outcomes
During this period, 642 patients completed their treatment at the pain management service,
representing 44.8% of the total patients registered. Approximately one third of these patients
(n=206, 32.1%) and their carers (n=199, 31.0%) completed questionnaires both at referral and at the
end of their episode. T- and z-tests showed that these children did not differ significantly from the
larger population of children registered in PaedePPOC in terms of gender, age, country of birth, or
scores at referral on all assessment tools (all p values >0.05).
The referral and episode end scores for these children are shown in Table 5.
Table 5 here
In this small sub-sample with follow-up data, and using the clinically significant criteria described
previously, 49.3% of children and 48.7% of parents reported that the child’s average pain improved
by at least 30% from referral to episode end. Change in the child’s health-related quality of life
reached clinical significance according to 68.9% of child-reports and 63.4% of parent-reports. Over
half (58.9%) of the children experienced a clinically significant improvement in their functional
ability. There was a statistically significant decrease in scores measuring pain-specific anxiety (t=8.60,
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p < 0.0001), and 48.4% of adolescents reported at least a 30% improvement from referral to episode
end.
These improvements were accompanied by a reduction in the number of school days missed due to
pain. At referral children missed a median of 10 days in the previous school term (interquartile range
4-21 days) and at episode end these figures were 5 days (0-15 days). Reductions in medications used
often or daily for pain at referral and episode end are shown in Table 6.
Table 6 here
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DISCUSSION [1525/1500 words]
This foundation paper describes the processes whereby the Australian and New Zealand electronic
Persistent Pain Outcomes Collaboration for children’s specialist pain services (PaedePPOC) was
established. Years of advocacy by professional and consumer groups, together with seed funding
from the NSW Ministry of Health, catalysed the process. Thereafter, consensus on the PaedePPOC
dataset, and roll-out of protocols, software and training were achieved within 18 months. Nine of
the ten specialist paediatric pain services in Australia and New Zealand are now participating in
PaedePPOC.
A number of factors facilitated the establishment and implementation of PaedePPOC. The most
important of these was the parallel establishment of the adult pain outcomes collaboration.65 The
synergy between the two meant that critical infrastructure and processes were already in place and
could be modified rather than developed anew. For example, the epiCentre database, adult ePPOC
service-level reports, training and support processes were amended to address the needs of the
paediatric services. This also significantly reduced the cost of implementing PaedePPOC.
A second factor facilitating implementation was the relatively small number of children’s pain
services in Australasia, enabling all services to participate in meetings to discuss the development of
PaedePPOC. Arriving at consensus on the minimum dataset was therefore able to occur relatively
quickly. The small number of services also meant that existing ePPOC staff could accommodate the
training, support and reporting requirements of PaedePPOC.
Other factors perhaps less unique to the Australasian environment were: 1) the importance placed
on the dataset being useful for clinical purposes, with reporting, benchmarking and research as
secondary uses of the data; 2) the development of purpose-built software for the collection and
clinical use of the information; and 3) ongoing support and contact with the pain management units.
Each of these helped to ensure focus and engagement of pain service staff with PaedePPOC, and to
embed use of the questionnaires and software into routine clinical practice.
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There have been a number of benefits arising from the implementation of PaedePPOC. At the
national level, the data have permitted a detailed description of the children referred for specialist
pain management. Although limited, outcome data also indicate that a large proportion of the
children who completed their treatment made important positive change in the intensity of pain
experienced, their functional ability and health-related quality of life. The comparison of our
population and outcomes with those described in other countries and settings will allow and inform
discussion of issues including referral patterns, treatments provided and availability of services in
this country compared to others.
At the service level, the individual pain unit reports have allowed each service to better understand
the children they serve and to compare them to those seen elsewhere in Australia and in other
countries. This latter comparison may be particularly useful in determining the extent to which
scientific evidence derived in other countries and cultures (for example38) might be generalizable to
the Australasian or individual service contexts.
The process of embedding PaedePPOC into service ‘standard business’ has yielded other, unforeseen
benefits, beyond the information gained. The need to standardise terms to describe episodes, care
pathways and service events has led to rich discussion and acknowledgement of the variation in
practice across units. Having to label points of care as being on one pathway or another, or
identifying the end of an episode of active care, required service teams to reflect and make explicit
any plan changes. When an episode of active care is ended explicitly, this raises the probability that
there will follow a clear hand-over of care to the referring doctor, complete with follow-on care
advice and contingency plans for children and families.
The use of individual patient reports and graphics in conversations with young people and/or
parents has also acknowledged, in a real way, consumer-ownership of their healthcare information,
and improved engagement in treatment. This is consistent with the findings of a recent study
highlighting the benefits of discussing patient-rated outcomes with the patient.32 Within the
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children’s services, completion of subsequent questionnaires may also be more likely if the child and
parent see that their responses inform treatment and are used to monitor progress. Another
hypothesis is that PaedePPOC participation increases child and family sense of their own altruistic
contribution to a greater good, and may contribute to post-traumatic growth.
While PaedePPOC has been embraced by children’s specialist pain services in Australasia, its
implementation has not been without challenges. A number of these were mentioned previously,
including the difficulties deploying epiCentre, additional burden of data entry for pain service staff,
and reconciling an existing service’s processes and procedures with the PaedePPOC protocol.
Another ongoing challenge and important limitation in the data currently collected is that it may not
reflect all patients referred for pain management. While the expectation of PaedePPOC is that each
pain management service will submit data for all patients, the current data indicate that just over
75% of children and parents completed a referral questionnaire. There may be valid reasons for a
proportion of these non-completions, for example, questionnaires not received at the time of data
extraction, or referred patients failing to attend. In addition, because baseline and outcome
information is self- or parent-reported, it is only available if the individuals are able to complete the
questionnaires. PaedePPOC is looking to address these issues by promoting the use of
questionnaires available in other languages, and investigating processes within each hospital to help
ensure patient information is collected for all patients. It is possible, however, that people with low
literacy or intellectual impairment will be underrepresented in the PaedePPOC dataset.
Another perennial challenge for outcome registries is to capture data from patients at and after
discharge from active care.7,65 This is clearly apparent in the PaedePPOC data reported here, with a
small number of episode outcomes available relative to the number of children referred. The
reasons for this may include losing contact with patients and limited availability of resources to send
and monitor questionnaires. However we believe that one of the primary reasons, which became
apparent in the early stages of both PaedePPOC and ePPOC, was that episodes of specialist pain care
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were often lengthy or nebulous. Many services did not discharge patients, while others had no clear
process for identifying when treatment was complete. This meant that a measure of treatment
outcome may never be obtained for a large proportion of patients. In order to address this and
maximise the number of episode outcomes that could be obtained, a definitional change to the ‘end
of episode’ was made. Whereas an episode end was previously defined as the point of discharge
from a service, the definition now relates to when ‘active treatment’ is complete. This may be at the
end of a defined treatment (e.g. a group pain program or series of individual appointments) or when
the treating clinicians reduce the frequency of appointments from therapy to maintenance levels. It
is expected that this will lead to an increased proportion of episode closures and outcomes in the
future. Outcome data is critical to the aims of PaedePPOC, and the ongoing viability of the
collaboration will depend on how successful we are in our ability to gather this information in future.
One further challenge is assuring the financial sustainability of the collaboration. ePPOC and
PaedePPOC are jointly funded by the primary stakeholders – individual pain management services,
state governments, and insurance and compensation organisations. These organisations fund the
maintenance of the ePPOC/PaedePPOC infrastructure and staffing necessary to carry out the
functions of the collaborations. In addition, participating services must manage the sustainability of
their own participation including managing communications with patients, data entry and
extraction, attendance at PaedePPOC meetings, and managing review of service reports as part of
internal quality improvement activities. For the sector and consumers to benefit from PaedePPOC
into the future, its financial and service-level sustainability must remain a focus area.
The years 2014 to 2018 have marked the establishment phase of PaedePPOC, with the emphasis on
dataset development and integration into clinical processes. The next three years will focus on
increasing collection of outcome data and establishing benchmarks for the sector. Benchmarks have
been created for the adult pain services and will be used in PaedePPOC to identify reasons for
variation between services and the practices and processes that result in the best outcomes for
patients. As baseline and outcome data builds there will also be an increased focus on use of the
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data for research. For example, future research will examine concordance between self- and proxyreports, identification of children whose outcomes are positive compared to those that are not
including the factors related to or predictive of these, and use of the patient linkage key in
PaedePPOC and ePPOC to identify those children who transition to or re-appear in adult services
This paper describes the evolution of PaedePPOC in services across Australia and New Zealand. We
hope that service clinicians and planners may see in this description, elements that could inform the
development of persistent pain outcome registries in other jurisdictions. The drivers, collaborative
processes, and dataset may be relevant or adapted to other, similar initiatives. Ultimately,
international collaboration will be facilitated by gradually aligning outcome measurement suites
across borders.
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Figure 1. Graphic representation of a 13 year old child’s self-reported progress.
The top left panel shows pain severity ‘in the last week’ rated at referral and review dates using the
modified-BPI, where 0 = ‘no pain’ and 10 = ‘pain as bad as you can imagine’. The top right panel
shows quality of life ‘in the last month’ using PedsQL subscale and total scores, where 0 = all
activities rated as ‘almost always’ a problem, and 100 = all activities rated as ‘never’ a problem. The
bottom left panel shows functional disability ‘in the last two weeks’ using FDI scores at referral and
review overlying FDI disability severity bands. An FDI score of 0 = all 15 physical activities were rated
as being ‘no trouble’, and 60 = all activities were rated as ‘impossible’. The bottom right panel shows
pain-related worries ‘in the last two weeks’ rated on the BAPQ Section 5, where 0 = all seven
worries/thoughts scored as ‘never’ experienced, and 28 = all seven worries/thoughts scored as
‘always’ experienced. These graphics can be used to discuss progress with the young person and
their family in clinic, and may be included in clinic letters to update the referring practitioner.
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Figure 2. Data collection flow diagram.
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Table 1. Data collection domains and their sources
From PedIMMPACT 53

From Adult ePPOC 65

Additional

Included:

Included all:

Added:

• Pain intensity

• Episode of care details

• Physical functioning

• Demographics

• Emotional functioning

• Comorbidities

• Impact of child’s pain
on the primary parent or
carer

• Role functioning

• Pain description

• Sleep

• Healthcare utilization

Omitted:
• Treatment-emergent
adverse
symptoms/events
• Global judgement of
satisfaction with
treatment
• Economic factors

• Medication usage

Table 2. Measurement tools used in Paed-ePPOC
Domain

Variable

Measurement Tool(s)

Age group
(Source)

Pain

Context

Categorical options for how pain began,
duration since onset, and association with
cancer or compensation
CARRA Body-chart for worst pain site and all
pain sites
Five categorical options – always present with
constant intensity, always present but varying
intensity, often, occasionally or rarely present
Pain now, and best, worst and usual pain during
the last week using either the Faces of Pain
Scale-R for children 5-7 years or Modified Brief
Pain Inventory for all older children and parent
report
Functional Disability Inventory

All (P)

Location
Frequency

Intensity

Physical
functioning

Emotional
functioning

Role
functioning

Sleep
Medication
usage
Healthcare
Utilization

Parent impact
of child’s pain

Severity of
limitation
Frequency of
limitation
Pain-related
worries
Frequency of other
negative emotions

Pediatric Quality of Life physical function

All (C+P)
5-7 years (P)
8-12 years (C+P)
13-18 years (C+P)
All (C+P)

8-12 years (C)
13-18 years (C)
All (C+P)

Bath Adolescent Pain Questionnaire (Section 5
– pain-related worry)
Pediatric Quality of Life emotional function

13-18 years (C)

School days missed
If child was employed, reduction in work hours
due to pain
School and peer
Pediatric Quality of Life school and peer
function
function
Trouble sleeping
Pediatric Quality of Life single question about
sleep
Frequency of use of Categorical options to indicate use daily, often,
key drug groups
sometimes, rarely, never
Utilization of health Questions regarding general practitioner,
care services in the specialist, allied health, alternative therapists,
last 3 months
emergency department visits, admissions to
hospital and diagnostic test usage in the last
three months
Work capacity
Reduced hours
Impact on parental Bath Adolescent Pain Parent Impact
mood, cognitions,
Questionnaire
relationships

All (P)
13-18 years (P)

School attendance
Work capacity

C – child/adolescent self-report; CARRA – Childhood Arthritis and Rheumatology Research
Alliance; P – parent proxy-report

All (C+P)

All (C+P)
All (C+P)
All (P)
All (P)

All (P)
All (P)

Table 3. Demographic information and comorbidities of children at referral
Gender, N (%) (n=1432) †
- Male

452 (31.6)

- Female

980 (68.4)

Age in years, mean (SD) (n=1432)
- Male

11.7 (3.2)

- Female

12.8 (2.9)

Age group, N (%) (n=1432)
- < 5 years

23 (1.6)

- 5 – 7 years

73 (5.1)

- 8 – 12 years

523 (36.5)

- 13 – 18 years

813 (56.8)

Country of birth, N (%) (n=1141)
- Australia
- Other
Aboriginal and/or Torres Strait Islander, N (%) (n=1020)

1063 (93.2)
78 (6.8)
52 (5.1)

Comorbidities and disabilities, N (%) (n=1076)
- chronic disease

224 (20.8)

- mental health condition

256 (23.8)

- cancer

20 (1.9)

- sight impairment

71 (6.6)

- hearing impairment

22 (2.0)

- intellectual disability

23 (2.1)

- physical disability

80 (7.4)

† n – Number of baseline questionnaires wherein the given demographic field was
completed by respondents
SD – Standard deviation

Table 4. Child and parent scores on assessment tools at referral, by age group

Outcome measure

Mean score (SD)
Child report

Parent report

Young Children (5-7 years)

n=32

n=70

Pain Severity – Worst pain

7.0 (3.0)

7.0 (2.3)

– Average pain
– Total score

4.9 (2.7)
53.0 (15.9)

5.2 (1.9)
49.2 (17.8)

– Emotional
– Social

45.6 (27.2)
63.2 (24.3)

47.2 (19.1)
60.9 (24.8)

– School
– Physical

58.1 (21.3)
48.1 (19.0)

54.8 (21.1)
40.6 (24.4)

– Sleep

32.3 (37.9)

37.3 (32.3)

n=396

n=403

7.6 (2.1)
5.7 (2.4)
50.8 (17.5)
49.8 (22.4)
65.9 (21.5)
53.0 (22.0)
40.8 (23.9)
32.7 (32.1)
25.7 (12.0)

7.6 (2.2)
5.5 (2.1)
47.6 (17.1)
46.7 (20.8)
61.8 (21.6)
49.8 (22.2)
37.9 (23.9)
34.7 (31.7)
n/a

n=648

n=635

7.7 (1.8)
5.7 (2.0)
48.0 (17.9)
50.1 (23.0)
65.0 (23.7)
44.0 (22.7)

7.5 (2.0)
5.7 (1.9)
44.8 (16.4)
45.8 (21.0)
60.2 (21.4)
41.5 (21.5)

38.6 (21.6)
32.9 (32.0)

36.7 (21.6)
32.0 (30.0)

26.8 (12.1)
15.1 (6.2)

n/a
n/a

PedsQL

Children (8-12 years)
Pain Severity – Worst pain
– Average pain
PedsQL
– Total score
– Emotional
– Social
– School
– Physical
– Sleep
FDI
Adolescents (13-18 years)
Pain Severity – Worst pain
– Average pain
PedsQL
– Total score
– Emotional
– Social
– School
– Physical
– Sleep
FDI
BAP-Q5

BAP-Q5 – Bath Adolescent Pain Questionnaire, Pain-related worry section; FDI – Functional
Disability Inventory; n – Number of baseline questionnaires wherein this field was validly
completed by respondents; n/a – Not applicable as parent-proxy questionnaires are not
collected; PedsQL – Pediatric Quality of Life Inventory, Generic core scales; SD – Standard
deviation

Table 5. Scores at referral and episode end – mean (SD)

Child report

Parent report

n

Referral
score

p-value†
Episode
end score for change

n

Referral
score

Episode
p-value†
end score for change

– Worst

202

7.8 (1.8)

5.7 (3.1)

<0.0001

188

7.7 (2.0)

5.3 (3.1)

<0.0001

– Average

201

5.7 (2.0)

3.7 (2.5)

<0.0001

187

5.6 (1.8)

3.7 (2.3)

<0.0001

Pain Intensity

PedsQL
– Total

196 47.6 (17.0) 64.1 (21.6)

<0.0001

182 45.5 (14.9) 58.1 (20.5)

<0.0001

– Emotional

193 49.3 (22.1) 66.4 (23.8)

<0.0001

182 47.9 (18.3) 58.1 (22.9)

<0.0001

– Social

195 63.3 (23.3) 72.7 (22.8)

<0.0001

182 59.3 (21.3) 66.9 (23.6)

<0.0001

– School

195 46.9 (22.3) 60.7 (25.9)

<0.0001

180 44.4 (21.8) 57.3 (24.8)

<0.0001

– Physical

196 37.4 (21.5) 59.6 (25.3)

<0.0001

182 36.0 (20.7) 53.3 (24.6)

<0.0001

– Sleep

189 30.6 (31.8) 50.9 (38.0)

<0.0001

179 33.4 (31.3) 48.6 (33.7)

<0.0001

FDI

201 26.9 (11.3) 16.2 (12.6)

<0.0001

na

na

na

na

BAP-Q5

122

<0.0001

na

na

na

na

15.0 (5.9)

10.5 (6.0)

† – p-value based on paired t-test; BAP-Q5 – Bath Adolescent Pain Questionnaire, Painrelated worry section; FDI – Functional Disability Inventory; n – the total number of child and
parent questionnaire pairs with valid data for both time points; n/a – Not applicable as
parent-proxy questionnaires are not collected; PedsQL – Pediatric Quality of Life Inventory,
Generic core scales; SD – Standard deviation

Table 6. Medications used often or daily at referral and episode end, parent report

Number with
data for both
time points

Using drug class
at referral
n (%)

Using drug class
at episode end
n (%)

p value* for
change

Paracetamol
(acetaminophen)

189

109 (57.7)

68 (36.0)

<0.0001

Non-steroidal antiinflammatory drugs

169

91 (53.8)

55 (32.5)

<0.0001

Complementary and
alternative medicines

175

54 (30.9)

41 (23.4)

0.0533

Opioids (including
codeine)

162

31 (19.1)

21 (13.0)

0.0872

Anti-neuropathic pain
medications

175

61 (34.9)

66 (37.7)

0.5758

Drug Class

* p-value based on McNemar’s test
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